The global HIV Integrase Strand Transfer Inhibitors (INSTI) market size was valued at US$ 7.34 billion in 2024 and is projected to reach US$ 11.26 billion by 2030, at a CAGR of 7.4% during the forecast period 2024-2030.
United States HIV Integrase Strand Transfer Inhibitors (INSTI) market size was valued at US$ 3.56 billion in 2024 and is projected to reach US$ 5.38 billion by 2030, at a CAGR of 7.1% during the forecast period 2024-2030.
INSTIs are a class of antiretroviral medications that block the action of integrase, an HIV enzyme, to prevent viral replication.
Strong growth supported by increasing adoption as preferred first-line HIV treatment regimens. Long-acting formulations driving market expansion. Generic entry for some INSTIs in certain markets may impact overall market value.
Report Overview
This report provides a deep insight into the global HIV Integrase Strand Transfer Inhibitors (INSTI) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the HIV Integrase Strand Transfer Inhibitors (INSTI) market in any manner.
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Adcock Ingram Limited
- Affine Formulations Limited
- Aurobindo Pharma
- Biocon Limited
- Bristol-Myers Squibb
- Cipla
- Emcure Pharmaceuticals
- Flamingo Pharmaceuticals Limited
- Gilead Sciences
- Hetero Drugs
- IPCA Laboratories
- Janssen Pharmaceutica (Johnson & Johnson)
- LAURUS Labs
- Medisist Pharma
- Merck
- Mylan
- Ranbaxy Pharmaceuticals
- Shanghai Desano Pharmaceuticals
- ViiV Healthcare (GSK)
Market Segmentation (by Type)
- Raltegravir
- Elvitegravir Combination Drugs
- Dolutegravir and Its Combination Drug
- Bictegravir Combination Drug
- Cabotegravir
- Other
Market Segmentation (by Application)
- Hospital
- Clinic
- Drug Center
- Other
- Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the HIV Integrase Strand Transfer Inhibitors (INSTI) Market
- Overview of the regional outlook of the HIV Integrase Strand Transfer Inhibitors (INSTI) Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of HIV Integrase Strand Transfer Inhibitors (INSTI)
1.2 Key Market Segments
1.2.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Segment by Type
1.2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Overview
2.1 Global Market Overview
2.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Competitive Landscape
3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Manufacturers (2019-2024)
3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Manufacturers (2019-2024)
3.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Sites, Area Served, Product Type
3.6 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Competitive Situation and Trends
3.6.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Rate
3.6.2 Global 5 and 10 Largest HIV Integrase Strand Transfer Inhibitors (INSTI) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Chain Analysis
4.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of HIV Integrase Strand Transfer Inhibitors (INSTI) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Type (2019-2024)
6.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2019-2024)
6.4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Price by Type (2019-2024)
7 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Sales by Application (2019-2024)
7.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (M USD) by Application (2019-2024)
7.4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Growth Rate by Application (2019-2024)
8 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segmentation by Region
8.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Region
8.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Region
8.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Region
8.2 North America
8.2.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Adcock Ingram Limited
9.1.1 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.1.2 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.1.4 Adcock Ingram Limited Business Overview
9.1.5 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) SWOT Analysis
9.1.6 Adcock Ingram Limited Recent Developments
9.2 Affine Formulations Limited
9.2.1 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.2.2 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.2.4 Affine Formulations Limited Business Overview
9.2.5 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) SWOT Analysis
9.2.6 Affine Formulations Limited Recent Developments
9.3 Aurobindo Pharma
9.3.1 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.3.2 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.3.4 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) SWOT Analysis
9.3.5 Aurobindo Pharma Business Overview
9.3.6 Aurobindo Pharma Recent Developments
9.4 Biocon Limited
9.4.1 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.4.2 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.4.4 Biocon Limited Business Overview
9.4.5 Biocon Limited Recent Developments
9.5 Bristol-Myers Squibb
9.5.1 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.5.2 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.5.4 Bristol-Myers Squibb Business Overview
9.5.5 Bristol-Myers Squibb Recent Developments
9.6 Cipla
9.6.1 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.6.2 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.6.4 Cipla Business Overview
9.6.5 Cipla Recent Developments
9.7 Emcure Pharmaceuticals
9.7.1 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.7.2 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.7.4 Emcure Pharmaceuticals Business Overview
9.7.5 Emcure Pharmaceuticals Recent Developments
9.8 Flamingo Pharmaceuticals Limited
9.8.1 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.8.2 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.8.4 Flamingo Pharmaceuticals Limited Business Overview
9.8.5 Flamingo Pharmaceuticals Limited Recent Developments
9.9 Gilead Sciences
9.9.1 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.9.2 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.9.4 Gilead Sciences Business Overview
9.9.5 Gilead Sciences Recent Developments
9.10 Hetero Drugs
9.10.1 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.10.2 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.10.4 Hetero Drugs Business Overview
9.10.5 Hetero Drugs Recent Developments
9.11 IPCA Laboratories
9.11.1 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.11.2 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.11.4 IPCA Laboratories Business Overview
9.11.5 IPCA Laboratories Recent Developments
9.12 Janssen Pharmaceutica (Johnson and Johnson)
9.12.1 Janssen Pharmaceutica (Johnson and Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.12.2 Janssen Pharmaceutica (Johnson and Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.12.3 Janssen Pharmaceutica (Johnson and Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.12.4 Janssen Pharmaceutica (Johnson and Johnson) Business Overview
9.12.5 Janssen Pharmaceutica (Johnson and Johnson) Recent Developments
9.13 LAURUS Labs
9.13.1 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.13.2 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.13.4 LAURUS Labs Business Overview
9.13.5 LAURUS Labs Recent Developments
9.14 Medisist Pharma
9.14.1 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.14.2 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.14.4 Medisist Pharma Business Overview
9.14.5 Medisist Pharma Recent Developments
9.15 Merck
9.15.1 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.15.2 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.15.4 Merck Business Overview
9.15.5 Merck Recent Developments
9.16 Mylan
9.16.1 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.16.2 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.16.4 Mylan Business Overview
9.16.5 Mylan Recent Developments
9.17 Ranbaxy Pharmaceuticals
9.17.1 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.17.2 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.17.4 Ranbaxy Pharmaceuticals Business Overview
9.17.5 Ranbaxy Pharmaceuticals Recent Developments
9.18 Shanghai Desano Pharmaceuticals
9.18.1 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.18.2 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.18.4 Shanghai Desano Pharmaceuticals Business Overview
9.18.5 Shanghai Desano Pharmaceuticals Recent Developments
9.19 ViiV Healthcare (GSK)
9.19.1 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
9.19.2 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
9.19.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Market Performance
9.19.4 ViiV Healthcare (GSK) Business Overview
9.19.5 ViiV Healthcare (GSK) Recent Developments
10 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Region
10.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast
10.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Country
10.2.3 Asia Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Region
10.2.4 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of HIV Integrase Strand Transfer Inhibitors (INSTI) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of HIV Integrase Strand Transfer Inhibitors (INSTI) by Type (2025-2030)
11.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of HIV Integrase Strand Transfer Inhibitors (INSTI) by Type (2025-2030)
11.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Application (2025-2030)
11.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units) Forecast by Application
11.2.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Comparison by Region (M USD)
Table 5. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2022)
Table 10. Global Market HIV Integrase Strand Transfer Inhibitors (INSTI) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Sites and Area Served
Table 12. Manufacturers HIV Integrase Strand Transfer Inhibitors (INSTI) Product Type
Table 13. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of HIV Integrase Strand Transfer Inhibitors (INSTI)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges
Table 22. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Type (K Units)
Table 23. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (M USD)
Table 24. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units) by Type (2019-2024)
Table 25. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Type (2019-2024)
Table 26. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (M USD) by Type (2019-2024)
Table 27. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Share by Type (2019-2024)
Table 28. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Price (USD/Unit) by Type (2019-2024)
Table 29. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units) by Application
Table 30. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
Table 31. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Application (2019-2024) & (K Units)
Table 32. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2019-2024)
Table 33. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Application (2019-2024) & (M USD)
Table 34. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2019-2024)
Table 35. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Growth Rate by Application (2019-2024)
Table 36. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Region (2019-2024) & (K Units)
Table 37. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Region (2019-2024)
Table 38. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Country (2019-2024) & (K Units)
Table 39. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Region (2019-2024) & (K Units)
Table 41. South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Region (2019-2024) & (K Units)
Table 43. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 44. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 45. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Adcock Ingram Limited Business Overview
Table 47. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) SWOT Analysis
Table 48. Adcock Ingram Limited Recent Developments
Table 49. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 50. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 51. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Affine Formulations Limited Business Overview
Table 53. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) SWOT Analysis
Table 54. Affine Formulations Limited Recent Developments
Table 55. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 56. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 57. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) SWOT Analysis
Table 59. Aurobindo Pharma Business Overview
Table 60. Aurobindo Pharma Recent Developments
Table 61. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 62. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 63. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Biocon Limited Business Overview
Table 65. Biocon Limited Recent Developments
Table 66. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 67. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 68. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Recent Developments
Table 71. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 72. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 73. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Cipla Business Overview
Table 75. Cipla Recent Developments
Table 76. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 77. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 78. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Emcure Pharmaceuticals Business Overview
Table 80. Emcure Pharmaceuticals Recent Developments
Table 81. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 82. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 83. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Flamingo Pharmaceuticals Limited Business Overview
Table 85. Flamingo Pharmaceuticals Limited Recent Developments
Table 86. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 87. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 88. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Gilead Sciences Business Overview
Table 90. Gilead Sciences Recent Developments
Table 91. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 92. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 93. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Hetero Drugs Business Overview
Table 95. Hetero Drugs Recent Developments
Table 96. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 97. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 98. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. IPCA Laboratories Business Overview
Table 100. IPCA Laboratories Recent Developments
Table 101. Janssen Pharmaceutica (Johnson and Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 102. Janssen Pharmaceutica (Johnson and Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 103. Janssen Pharmaceutica (Johnson and Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Janssen Pharmaceutica (Johnson and Johnson) Business Overview
Table 105. Janssen Pharmaceutica (Johnson and Johnson) Recent Developments
Table 106. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 107. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 108. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. LAURUS Labs Business Overview
Table 110. LAURUS Labs Recent Developments
Table 111. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 112. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 113. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Medisist Pharma Business Overview
Table 115. Medisist Pharma Recent Developments
Table 116. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 117. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 118. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Merck Business Overview
Table 120. Merck Recent Developments
Table 121. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 122. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 123. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Mylan Business Overview
Table 125. Mylan Recent Developments
Table 126. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 127. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 128. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Ranbaxy Pharmaceuticals Business Overview
Table 130. Ranbaxy Pharmaceuticals Recent Developments
Table 131. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 132. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 133. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Shanghai Desano Pharmaceuticals Business Overview
Table 135. Shanghai Desano Pharmaceuticals Recent Developments
Table 136. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Basic Information
Table 137. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Overview
Table 138. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. ViiV Healthcare (GSK) Business Overview
Table 140. ViiV Healthcare (GSK) Recent Developments
Table 141. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Forecast by Region (2025-2030) & (K Units)
Table 142. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Forecast by Country (2025-2030) & (K Units)
Table 144. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Forecast by Country (2025-2030) & (K Units)
Table 146. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Forecast by Region (2025-2030) & (K Units)
Table 148. Asia Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Forecast by Country (2025-2030) & (K Units)
Table 150. South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Forecast by Type (2025-2030) & (K Units)
Table 154. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 156. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units) Forecast by Application (2025-2030)
Table 157. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of HIV Integrase Strand Transfer Inhibitors (INSTI)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (M USD), 2019-2030
Figure 5. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (M USD) (2019-2030)
Figure 6. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (M USD)
Figure 11. HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Share by Manufacturers in 2023
Figure 12. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Manufacturers in 2023
Figure 13. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market HIV Integrase Strand Transfer Inhibitors (INSTI) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type
Figure 18. Sales Market Share of HIV Integrase Strand Transfer Inhibitors (INSTI) by Type (2019-2024)
Figure 19. Sales Market Share of HIV Integrase Strand Transfer Inhibitors (INSTI) by Type in 2023
Figure 20. Market Size Share of HIV Integrase Strand Transfer Inhibitors (INSTI) by Type (2019-2024)
Figure 21. Market Size Market Share of HIV Integrase Strand Transfer Inhibitors (INSTI) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application
Figure 24. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2019-2024)
Figure 25. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application in 2023
Figure 26. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2019-2024)
Figure 27. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application in 2023
Figure 28. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Growth Rate by Application (2019-2024)
Figure 29. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Region (2019-2024)
Figure 30. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Country in 2023
Figure 32. U.S. HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Country in 2023
Figure 37. Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Region in 2023
Figure 44. China HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (K Units)
Figure 50. South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Country in 2023
Figure 51. Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share Forecast by Type (2025-2030)
Figure 65. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Forecast by Application (2025-2030)
Figure 66. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share Forecast by Application (2025-2030)
